Coby White

Coby White has a diverse work experience in various companies. Coby started their career at Lockheed Martin Aeronautics, where they worked as a subcontract administrator and later as a senior financial analyst. Coby then joined Alcon, a Novartis company, as a senior analyst in business development and licensing. Coby was responsible for mergers and acquisitions, divestitures, and licensing agreements. Coby also worked as a senior financial analyst, where they led forecasting, budgeting, and cross-functional projects. Coby then moved to ZS Pharma, Inc., where they served as a senior manager in financial planning and analysis. Coby implemented an enterprise reporting and forecasting tool before the company was acquired by AstraZeneca. Coby then joined AstraZeneca as a director in financial planning and analysis, where they supported the integration of a legacy company. Currently, they are working as a senior director in financial planning and analysis at OncoNano Medicine, Inc. Their responsibilities include developing financial performance reporting and forecasting infrastructure, building and implementing new forecasting models, and assisting with investor and audit-related projects.

Coby White obtained a Bachelor of Business Administration (BBA) degree from the Texas McCombs School of Business between the years 1998 and 2002. During their undergraduate studies, they majored in Marketing and minor in Management Information Systems. Following their bachelor's degree, Coby pursued further education, completing their Master of Business Administration (MBA) at the Texas Christian University - M.J. Neeley School of Business from 2004 to 2006. The field of study for their MBA is not specified.